DBT approves additional funding to Gennova's mRNA-based COVID-19 vaccine candidate

Retrieved on: 2021-04-13 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

DBT approves additional funding to Gennova's mRNA-based COVID-19 vaccine candidate. View article details on hiswai:

Excerpt

Gennova, in collaboration with HDT Biotech Corporation, USA,has developed the COVID-19 mRNA vaccine – HGCO19. HGCO19 has already ...

Article found on: www.biospectrumindia.com